Myelin-associated glycoprotein (MAG) is a well-characterized axon growth inhibitor in the adult vertebrate nervous system. Several signals that play roles in inhibiting axon growth have been identified. Here, we report that soluble MAG induces activation of Rap1 in postnatal cerebellar granule neurons (CGNs) and dorsal root ganglion (DRG) neurons. The p75 receptor associates with activated Rap1 and is internalized in response to MAG. After MAG is applied to the distal axons of the sciatic nerves, the activated Rap1, internalized p75 receptor, and MAG are retrogradely trafficked via axons to the cell bodies of the DRG neurons. Rap1 activity is required for survival of the DRG neurons as well as CGNs when treated with MAG. Myelin-associated glycoprotein (MAG) is a member of the I-type lectin subgroup of the immunoglobulin (Ig) gene superfamily and is expressed exclusively by myelinating cells where it is enriched in the adaxonal membrane of the myelin internode. MAG inhibits neurite outgrowth from the adult dorsal root ganglion (DRG) and the postnatal ages of the cerebellar, retinal, spinal, hippocampal, and superior cervical ganglion neurons.
Myelin-associated glycoprotein (MAG) is a member of the I-type lectin subgroup of the immunoglobulin (Ig) gene superfamily and is expressed exclusively by myelinating cells where it is enriched in the adaxonal membrane of the myelin internode. MAG inhibits neurite outgrowth from the adult dorsal root ganglion (DRG) and the postnatal ages of the cerebellar, retinal, spinal, hippocampal, and superior cervical ganglion neurons. 1, 2 To date, two additional neurite growth inhibitors that are expressed by oligodendrocytes and myelinated fiber tracts have been identified. 3 These are Nogo and oligodendrocyte-myelin glycoprotein. All these proteins act on neurons through the Nogo receptor complex. This is a trimolecular complex comprising the Nogo receptor, Lingo-1, and p75/Troy. 4 A key intracellular effector for neurite growth inhibitory signaling by myelin was previously shown to be the small guanine nucleoside triphosphatase, RhoA. In its active GTP-bound form, RhoA rigidifies the actin cytoskeleton, thereby inhibiting axon elongation and mediating growth cone collapse. RhoA is activated by these proteins through a p75-dependent mechanism, thus inhibiting neurite outgrowth from the postnatal sensory neurons and cerebellar neurons. 5, 6 It was also demonstrated that conventional protein kinase C (PKC), including PKC-a, -b, and -g, was activated by the neurite growth inhibitory proteins, and the inhibition of conventional PKC eliminated the effect of these proteins on neurite outgrowth. 7, 8 In addition, phosphorylation of the epidermal growth factor (EGF) receptor is triggered by these myelin-derived inhibitors and is necessary for the inhibitory effect. 9 These multiple signals are responsible for the effects of the myelin-derived inhibitors at least in vitro.
In addition to the role of MAG in axon regeneration, experiments with MAG-deficient mice implicate this protein in regulating axonal caliber and the levels of neurofilament spacing in mature myelinated fibers. 10 MAG is suggested to modulate the maturation and viability of myelinated axons. These findings suggest the diverse functions of MAG in the nervous system.
In the course of identifying signals downstream of MAG, we found that Rap1 is activated in response to soluble MAG. Rap1 is a member of the Ras family of small guanine nucleotidebinding proteins (G proteins), which activate and inhibit several proteins in a GTP-dependent manner. 11 Rap1 is implicated in a particularly wide range of biological processes, from cell proliferation and differentiation to cell adhesion. Rap1 opposes the actions of Ras, including the regulation of cell growth and differentiation, integrin-dependent responses, and synaptic plasticity. Furthermore, recent evidence has demonstrated that Rap1, like Ras, can activate the mitogen-activated protein kinase cascade in several cell types. In this study, we demonstrate that MAG activates Rap1 through a p75-dependent mechanism and that Rap1 activity is required for the cell survival of neurons following stimulation with MAG.
Results
MAG induces activation of Rap1 in postnatal cerebellar granule neurons. To examine whether MAG influences the activity of Rap1 in myelin-responsive neurons, we treated serum-starved cerebellar granule neurons (CGNs) from postnatal day 7 (P7) rats with recombinant soluble MAG and assessed the activity of endogenous Rap1 by using a pull-down assay. The effector protein Ral guanine nucleotide dissociation stimulator (RalGDS) was used to specifically precipitate GTP-bound form of Rap1. A soluble chimeric form of MAG, consisting of the extracellular domain of MAG fused to the Fc region of human IgG (MAG-Fc), was used. It was previously shown that soluble MAG, released in abundance from myelin and found in vivo, and MAG-Fc could potently inhibit axonal growth. 12, 13 Our results revealed that soluble MAG-Fc (25 mg/ml) triggered Rap1 activation from 10 min to 4 h after its addition into the medium (Figure 1a) . In contrast, the activity of Ras, another member of the Ras family of small G proteins, was suppressed transiently and returned to the control level at 4 h ( Figure 1a ). These results support the notion that Rap1 opposes the actions of Ras. We then employed CGNs (P7) from mice carrying a mutation in the p75 gene to determine whether p75 is required for Rap1 activation by MAG-Fc. Although Rap1 was activated in the CGNs from wild-type mice 30 min after the MAG-Fc treatment, Rap1 activation by MAG-Fc could not be observed in CGNs from mice carrying a mutation in the p75 gene (Figure 1b) . Thus, activation of Rap1 by MAG-Fc is dependent on p75.
Rap1 associates with p75 intracellular domain. We next examined whether Rap1 associates with p75. Hemagglutinin (HA)-tagged full-length p75 and various forms of myc-tagged Rap1A or -B were transfected into 293T cells. Rap1A is ubiquitously expressed in tissues, whereas Rap1B is predominantly expressed in platelets. 11 In the p75 precipitates, an anti-myc antibody revealed the presence of the dominant-active (DA) form as well as of the wild-type but not of the dominant-negative (DN) form of Rap1A (Figure 1c ). Any form of Rap1B was not co-immunoprecipitated with p75 ( Figure 1c) . These results suggest that the GTP-bound form of Rap1A predominantly associates with p75 in the transfected 293T cells. However, we could not conclude that the DN form of Rap1A did not interact with p75. The expression level of the DN form was low, although we tried to express it at the equivalent level. We then examined the interaction of endogenous p75 with Rap1 by using lysates prepared from rat CGNs (P7). An association of endogenous p75 with Rap1 was observed when the cells were treated with MAG-Fc but not in the absence of MAG-Fc (Figure 1d ). This result is consistent with the observation that Rap1 was activated in response to MAG-Fc ( Figure 1a ) and that the active form of Rap1 predominantly interacted with p75 ( Figure 1c ). These findings demonstrate that Rap1 is activated in CGNs when treated with MAG-Fc and that Rap1 associates with p75 presumably in the GTP-bound form.
We next examined the direct physical interaction of p75 with Rap1 using purified recombinant proteins. Bacterially produced His-tagged Rap1A in the GDP-bound, GTP-bound, or in the nucleotide-depleted state was incubated with the glutathione S-transferase (GST) fusion protein containing the intracellular domain (ICD) of p75 (GST-p75ICD). We observed the interaction of GST-p75ICD with Rap1A predominantly in the GTP-bound or nucleotide-free state but only weakly in the GDP-bound state (Figure 1e ). This pattern of association is similar to that of Rap1A and its effector RalGDS (Figure 1e ). We then assessed the structural basis of the interaction between Rap1A and p75ICD. Experiments with partial fragments of p75ICD showed that constructs that included the 'linker region' but not those that included the six a helices of p75 interacted with Rap1A (Figure 1f) . However, the interaction of Rap1A with p75ICD was stronger than that with the linker region (LR), suggesting that the helical domain (HD) might enhance the interaction. We previously showed that RhoGDI in complex with RhoA associates with the HD of p75.
14 Therefore, our mapping study shows distinct binding sites for Rap1 and RhoA-RhoGDI.
Internalization and trafficking of p75. We next hypothesized that p75 is internalized and trafficked after stimulation with MAG-Fc in the neurons. Although the internalization of p75 by neurotrophin binding has been demonstrated, 15, 16 there is no evidence for MAG-induced p75 internalization. We addressed this question by using DRG neurons as CGNs are too small for visualization and the DRG neurons constitute a well-established experimental system to study the effects of MAG. p75 was labeled with the MC192 monoclonal antibody (MC192).
17 MC192 binds to an extracellular epitope on rat p75 that is distinct from the binding site for nerve growth factor (NGF). The DRG neurons were incubated for 30 min with Alexa 594-labeled MC192 followed by incubation with Alexa 488-labeled MAG-Fc at a concentration of 25 mg/ml in serum-free media (SFM) at 41C. After washing, the neurons were then incubated for 60 min at 371C in SFM followed by two washes in ice-cold acid to eliminate surface binding of MAG-Fc. Figure 2a shows that MAG-Fc-(green) and MC192-labeled p75 (red) were internalized and colocalized in the cell bodies and the neurites of the DRG neurons (also see Supplementary Figure 1S ). Although majority of the signals were colocalized, some of the MAG-Fc signals were negative for the MC192-labeled p75, raising the possibility that another receptor for MAG, Troy, may play a role.
We then used CGNs to confirm these results by biochemical analysis. The CGNs (P7) were treated with MAG-Fc and MC192 for 30 min and were then incubated in MAG-Fcfree media for up to 60 min. The result indicated that MAG-Fc was present in the cytosolic fraction of the CGNs at 15-60 min after the elimination of MAG-Fc from the medium (Figure 2b ). MC192 was co-internalized in a similar time course.
We next performed time-lapse video fluorescence microscopy to observe the movement of the labeled p75 in the DRG neurons. The DRG neurons from P7 rats were labeled with Alexa 594-conjugated MC192 for 30 min, washed, and then treated with MAG-Fc (25 mg/ml). Figure 2c p75 is retrogradely trafficked to the cell bodies of the sciatic nerves. The above results suggest that p75 transmits a retrograde signal. If Rap1 is activated by MAGFc at the distal axons, this activated Rap1 may be trafficked to the cell bodies. To assess this, we developed a method in which the isolated DRG neurons and sciatic nerves were used for studying axonal transport. 18 Three-centimeter sections of the sciatic nerve were placed between agarose gel slabs in a chamber in which the nerve ends were submerged in wells containing the collection buffer (Figure 3a) . The preparation was then incubated for up to 12 h. We determined whether MAG-Fc and p75 were Next, we performed time-course experiments to measure the p75 transport. The trafficking rate of the fluorescence signals for MC192 in the DRG neurons in the absence of MAG-Fc at the distal end of the sciatic nerves was slow; however, the signal movement was potentiated approximately three times by the addition of MAG-Fc (Figure 4a, b) . Thus, although there is a basal level of trafficking of p75 in MC192-treated neurons in the control condition, as described previously, 15 MAG-Fc clearly stimulated the trafficking of p75. Addition of NGF (50 ng/ml) also stimulated the movement of the MC192 signal (Figure 4a, b) . We then employed DRGs (P9) from mice carrying a mutation in the p75 gene to determine whether p75 is required for the transport of MAGFc. As expected, only faint signals for MAG-Fc were observed after the addition of MAG-Fc to DRGs from mice carrying a mutation in p75 (Figure 4c, d ).
Rap1 is activated in the DRGs after application of MAGFc to the distal end. Experiments with CGNs suggest that p75 carries activated Rap1 from the periphery to the cell bodies. To test this possibility, we examined whether MAGFc also causes Rap1 activation in the sciatic nerves by an in situ assay. To assess the activity of Rap1 in situ, the GSTfused protein of RalGDS (GST-RalGDS), an effector of Rap1, was used. The activated Rap1 was present in bright puncta distributed along axons in the MAG-Fc-treated nerves (for 3 h) (Supplementary Figures 3Sa, b, and 4S) but not in the Fc-treated or Siglec-9-Fc-treated control nerves (Supplementary Figures 3Sa, b, and 4S ). Rap1 was activated in a number of neurons located in the DRGs when the distal axons were treated with MAG-Fc for 12 h, whereas no activation could be seen in the DRG neurons treated with Fc or Siglec-9-Fc (Figure 5a, b, Supplementary Figure 4S) . We then employed DRGs from mice carrying a mutation in the p75 gene. Little activation of Rap1 was observed 12 h after the addition of MAG-Fc to DRGs from mice carrying a mutation in p75 (Figure 5c, d) . These results suggest that MAG-Fc, acting at distal axons, signals retrogradely through a mechanism that requires p75.
Inhibition of Rap1 activation induced by MAG-Fc enhances cell death of the neurons. MAG inhibits neurite outgrowth from the postnatal CGNs, and this effect is mediated by several factors, including RhoA, conventional PKC, and the EGF receptor. 6, 9 These findings prompted us to examine if the effect of MAG-Fc on neurite outgrowth is also dependent on Rap1 activity. We generated TAT-Rap1A DN and TAT-Rap1A DA -DN and DA forms of Rap1A fused with the N-terminal 11-amino-acid protein transduction domain of the human immunodeficiency virus protein TAT 19 -to enable the protein to gain entry into the cell. Both forms of TAT-Rap1A were efficiently incorporated into all of the treated CGNs (data not shown). Although a consensus has been reached that the DN mutants function in cells by competing with normal Ras family proteins for binding to their guanine nucleotide exchange factors, the 17N mutant of Rap1A does not always compete well with normal Rap1 for the guanine nucleotide exchange factors in vitro. 20 Thus, we determined whether Rap1A DN functioned in the cells we used and found that the addition of TAT-Rap1A DN to the CGNs indeed suppressed the Rap1 activation induced by MAG-Fc (Figure 6a ). Transduction of TAT-Rap1A DN did not modulate the effect of MAG-Fc on neurite outgrowth (Supplementary Figure 5S) , demonstrating that the activation of Rap1 is not necessary for the inhibitory effect of MAG-Fc on neurite outgrowth. Furthermore, TAT-Rap1A DA did not mimic the effect of MAG-Fc (Supplementary Figure 5S) . As shown previously, 21 addition of MAG-Fc activated extracellular signal-regulated kinases (ERKs) in the CGNs. However, transduction of TAT-Rap1A DN did not modulate the ERKs phosphorylation induced by MAG-Fc (Supplementary Figure 6S) , although ERK activation has been implicated in MAG-induced growth inhibition. These results exclude the possibility that Rap1 plays a role in regulating the neurite outgrowth of CGNs.
Interestingly, we noticed that there was a net decrease in the number of cells when the cells were treated with MAG-Fc in combination with TAT-Rap1A DN (data not shown). To address the hypothesis that Rap1 is primarily involved in the survival of CGNs when stimulated with MAG, terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling (TUNEL) staining was performed. The number of TUNEL-positive cells was significantly increased in CGNs that were pretransduced with TAT-Rap1A DN and then treated with MAG-Fc ( Figure 6b, c) ; however, neither the TAT protein nor TAT-Rap1A DN by itself had any proapoptotic effect. These results demonstrate that the activation of Rap1 induced Finally, the functional implication of the retrograde signals was assessed using the sciatic nerves. TAT-Rap1A DN was applied to the cell bodies of DRG neurons (Figure 6d ). We immunostained DRG neurons with an anti-myc antibody to test for the transduction of the TAT-fused protein and found that TAT-Rap1A DN was efficiently incorporated into DRG neurons (52.8%; Supplementary Figure 7S (Figure 6f ). Thus, MAG-Fc applied to the distal axons of the sciatic nerves induced activation of Rap1 in the axons and the cell bodies of the DRG neurons and inhibition of the Rap1 activity elicited cell death of the DRG neurons when stimulated with MAG-Fc. As TAT-Rap1A DN itself showed slight toxicity in these cells, basal Rap1 activity may be necessary for maintaining cell survival of these neurons. These findings show that activated Rap1, presumably in complex with p75, is trafficked from the distal axons to the cell bodies and that the Rap1 activity induced by MAG-Fc is required for the cell survival of DRG neurons and CGNs when stimulated with MAG. 
Discussion
In the present study, we identified a new signal elicited by MAG. Rap1 is activated in the CGNs and DRG neurons when treated with soluble MAG. In a sciatic nerve explant culture, soluble MAG applied to the distal axons induced internalization and retrograde transport of p75 as well as MAG. p75 appears to be transported with activated Rap1 as the signals for these proteins colocalized and the activated Rap1 associated with p75 in vitro. Rap1 activity was necessary for the cell survival of DRG neurons stimulated with MAG at the distal axons and the MAG-treated CGNs. These findings support a role for p75 and soluble MAG in trafficking the survival signal to the cell bodies.
Internalization and trafficking of p75. Our data demonstrate that MC192 was retrogradely transported in the sciatic nerves. MC192 binds to an extracellular epitope on rat p75 that is distinct from the binding site for NGF. Moreover, MC192 binding does not deleteriously affect NGF signaling in pheochromocytoma (PC12) cells 17, 22, 23 or neurons. 24 Our preliminary data show that MC192 did not influence the effect of MAG on neurite growth (data not shown). It was reported that the internalization of fluorescence-labeled MC192 in the absence of a ligand was slow and equally potentiated by NGF or brain-derived neurotrophic factor. 15 As these findings were confirmed in our experimental models (Figure 4a, b) , MC192 proves to be an excellent tool to analyze the localization of p75 in situ.
Neurotrophin binding to p75 induces internalization through the clathrin-mediated internalization pathway to the recycling endosome. 15 Ligation of MAG to its receptor complex may regulate interaction with specific docking proteins; these might then sort the receptor to the retrograde transport pathway. Indeed, the association of p75 with the activated Rap1 supports this interesting possibility, and the internalized p75 may carry a signaling complex from the axon terminal to the cell body.
Although MAG typically functions as an intrinsic membrane protein, it was previously shown that soluble MAG, released in abundance from myelin and found in vivo, and MAG-Fc could potently inhibit axonal growth. 12, 13 It is also possible that the transport of p75 in complex with Rap1 does not require the internalization of MAG.
Target-derived signals, which emanate from remote axonal locations, transmit their messages to neuronal cell bodies. Retrograde endosomal signaling in neurons is a multistep process, and the molecular machinery that underlies these events is largely unknown. Retrograde signaling includes the internalization of ligand-receptor complexes in axon terminals, the sorting of complexes into active signaling vesicles, physical translocation of these endosomes along the axonal microtubule network to cell bodies, endosomal signaling, and the dismantling of the retrograde endosomal signaling complex. The molecular mechanisms that govern the retrograde transport of p75 and the endosomal signaling complex should be clarified in the future. Then, we will be able to assess whether retrograde transport of p75 is necessary for its antiapoptotic effect by specific inhibition of p75 transport.
Bidirectional signals elicited by MAG. Our data show that the activation of Rap1 induced by MAG contributes to the cell survival of CGNs as well as DRG neurons. However, MAG by itself had no antiapoptotic activity in the systems used, suggesting that there is an unidentified cell death-inducing signal downstream of MAG. This signal may counteract the Rap1 signal. It was reported that the application of the Rho antagonist C3-05 reduced the number of TUNEL-positive cells by B50% in both rats and mice with spinal cord injuries, 25 suggesting that Rho may be the signal responsible for cell death. Our preliminary data demonstrate that the application of Y-27632 -a Rho-kinase inhibitor -reduced the number of TUNEL-positive CGNs that were pretreated with TAT-Rap1 DN and then incubated with MAG-Fc (data not shown). Therefore, we reason that Rho-kinase and Rap1 may elicit opposite signals and that the balance of these signals might be important for determining the fate of neurons particularly in pathological conditions. The pathological relevance of Rap1 activation by the neurite outgrowth inhibitor MAG is unclear. The activation of Rap1 may be required to maintain viable neurons when they are damaged and exposed to the outgrowth inhibitors in myelin, which triggers neurite retraction by activating Rho/Rhokinase. The crosstalk between the survival signal and the proapoptotic signal needs to be elucidated.
Function of Rap1. Rap1 is implicated in a particularly wide range of biological processes. 11 It regulates a number of intracellular target proteins and antagonizes Ras. Rap1A is ubiquitously expressed in tissues, whereas Rap1B is predominantly expressed in platelets. The activation of Rap1 was not necessary for the inhibitory effect of MAG on neurite outgrowth in vitro (Supplementary Figure 5S) . Rap1 is a critical mediator in the control of integrin activation, and the activation of Rap1 correlates with increased adhesion rather than repulsion. 11 In our experimental paradigm, however, we did not determine neuronal adhesion.
Rap1 can bind to and activate the related Raf isoform B-Raf, which subsequently activates ERKs in some cells. In neuronal cells and megakaryocytes, Rap1 induces sustained activation of ERKs. In PC12 cells, the sustained activation of ERKs is required for neuronal differentiation induced by NGF. 26, 27 The activation of Rap1 by NGF requires the internalization of TrkA in intracellular vesicles containing Rap1, B-Raf, MEK, and ERK. 28 Possible downstream signals of Rap1 that contribute to cell survival are ERKs. Indeed, ERKs were activated from 10 min to 4 h in the CGNs after treatment with MAG-Fc (data not shown). However, as inhibitors of ERKs enhanced cell death by themselves (data not shown), we could not determine whether activation of ERK by MAG-Fc was necessary for the survival of the neurons in our experimental models.
p75 transduces the signals from MAG, Nogo, and oligodendrocyte-myelin glycoprotein. As other myelin-derived inhibitors are also involved in signaling, including RhoA and conventional PKC, it is suggested that Rap1 is activated by other inhibitors. In addition, another signal transducer of MAG -Troy -may substitute p75. Thus, the functional relevance of MAG-Rap1 in vivo could be assessed by double knockout of p75 and Troy. Our observations support the notion that internalized MAG and p75 can act as signaling platforms in neuronal cells and may be incorporated into signaling endosomes to mediate signals that promote neuronal survival.
Materials and Methods
All experimental procedures were approved by the institutional committee of Chiba University.
Animals.
A mouse strain bearing a targeted disruption of the third exon of the p75 gene 29 in a C57BL/6J background was used; the strain was originally obtained from Jackson Laboratory (Bar Harbor, Maine).
Cell culture. Dorsal root ganglia were removed from P7 rats or P7 mice and dissociated into single cells by incubation with 0.25% trypsin (Gibco BRL) for 30 min at 371C. For CGNs, cerebella were removed from P7 rats or P7 mice, mixed with 0.25% trypsin, triturated, and incubated with 200 U/ml DNase1 (TaKaRa) for 15 min at 371C. Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) containing 10% fetal calf serum was added, and the cells were centrifuged at 1000 r.p.m. for 5 min. Neurons were plated on poly-L-lysine-coated chamber slides. Where indicated, recombinant rat MAG-Fc chimera (25 mg/ml, R&D Systems) was added to the medium after plating.
Ras and Rap1 activity assays. Ras or Rap1 activity was assessed by employing the corresponding activation assay kits (Upstate Biotech). Briefly, treated cells were lysed in Mg 2 þ lysis buffer (MLB buffer) containing 25 mM HEPES, pH 7.5; 150 mM NaCl; 1% Igepal CA-630; 10 mM MgCl 2 ; 1 mM EDTA; 2% glycerol; 2 mM sodium orthovanadate; 1 mM sodium fluoride; and protease inhibitor mixture (Roche Diagnostics). To precipitate active Ras, cell lysates were incubated with 20 ml of the Raf-1-Ras-binding domain-agarose conjugate for 30 min at 41C. For Rap1, the Ral-binding domain of the RalGDS-agarose conjugate was used. The beads were washed with MLB buffer and resuspended in 2 Â sodium dodecyl sulfate (SDS) sample buffer. Anti-Ras antibody (Upstate Biotech) or anti-Rap1 antibody (BD Bioscience) was used for the blotting.
To assess the activity of Rap1 in situ, GST-RalGDS was used. The tissues were fixed in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB) at 41C overnight, rinsed in PB (pH 7.4), and cryoprotected in 30% sucrose. Cryostat sections (20 mm) were incubated with blocking solution containing 5% bovine serum albumin (BSA) and 0.3% Triton X-100 in PBS for 1 h, followed by overnight incubation with GST-RalGDS (5-10 mg/ml) at 41C. After rinsing, the sections were fixed again in 2% PFA in 0.1 M PB for 10 min at room temperature and were incubated with an anti-GST monoclonal antibody (diluted 1 : 400 in blocking solution, Santa Cruz Biotech) for 1 h at room temperature. Alexa 546-conjugated anti-mouse antibody (diluted 1 : 400 in PBS containing 0.1% Triton X-100, Invitrogen) was used as the secondary antibody. The number of cells with activated Rap1 in a fixed square (500 mm Â 500 mm) of the DRG was measured for rat experiments. Five DRGs for each group were measured in an experiment (n ¼ 5). Quantitative analysis of fluorescence intensity was performed using the National Institute of Health (NIH) image software, and the relative intensity in a fixed square (500 mm Â 500 mm) was measured (the signal intensity at 12 h after the MC192 plus MAG-Fc treatment in the wild-type mice was estimated as 100%). Five DRGs were analyzed for each group in one experiment (n ¼ 5).
